Lab. Pharm. Technology, University of Patras, Rio 26510, Greece or

Size: px
Start display at page:

Download "Lab. Pharm. Technology, University of Patras, Rio 26510, Greece +30-2610-969332 or 997725 +30-2610-996302 santimis@upatras.gr"

Transcription

1 ΒΙΟΓΡΑΦΙΚΟ ΣΗΜΕΙΩΜΑ: ΣΟΦΙΑ Γ. ΑΝΤΙΜΗΣΙΑΡΗ Ακολουθούν τα στοιχεία του βιογραφικού μου, στα Αγγλικά, όπως είχε πρόσφατα κατατεθεί σε πρόταση που υποβλήθηκε στο πρόγραμμα Αριστεία: I] Personal details / Education/ Affiliations Sophia G. Antimisiaris, Bpharm., Ph.D Current Position Professor of Pharmaceutics (2009-) and Lab Director (2002-), Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio, Greece Collaborating Faculty member, Institute of Chemical Engineering, ICEHT/FORTH (2006-to date) Personal Place and Date of Birth New Jersey, USA, 1962 Marital Status Married, two children Address Tel Fax Lab. Pharm. Technology, University of Patras, Rio 26510, Greece or Education Department of Pharmacy, University of Athens, Greece, Department of Pharmacy, University of Athens, Greece, Degree: BPharm (8.4/10) Degree: PhD (Biopharmaceutics) Supervisor: Prof. Panos Macheras Postdoctoral Research Assistant, School of Pharmacy, University of South California, Laboratory of Prof. Karl H.L. Hwang, Research on Liposomal Drug Delivery and Targeting. Affiliations: Lecturer of Pharmaceutics, Department of Pharmacy, UPAT (Sabbatical from UPAT) Visiting Professor, School of Pharmacy, University of London, Laboratory of Prof. Gregory Gregoriadis, Research on Liposomal Vaccine Delivery Assistant Prof, Department of Pharmacy, UPAT Associate Prof, Department of Pharmacy, UPAT Collaborating Member, Institute of Chemical Engineering, ICEHT-FORTH Research Activities: Nanomedicines: Liposomal or Nanoparticulate systems for Controlled Drug (or Vaccine) Delivery and/or Targeting Biopharmaceutics and Pharmacokinetics: Improving Drug Biodistribution and Pharmacokinetics through Advanced Drug Delivery System Design Application of novel lipid vesicles (Arsonoliposomes) in Anticancer / Antiparasitic Therapeutics. Novel Controlled-(Release)-Drug-Eluting Stents. Ocular, Alveolar and Vaginal Drug Delivery Systems Application of Liposomes in Analytical Techniques Participation in Research Projects: As coordinator/ or PI, in 1 National (PENED), 4 EU-funded (FP6/Interreg/FP7), and 3 industry funded projects (details below) 1

2 Publications: 75 papers in peer-reviewed journals (or series), 12 Invited Papers & Reviews or Chapters in Book Series, 120 Abstracts in proceeding of National, European and International conferences, 6 Papers in Greek Scientific Journals, 1 World patent, 1 PCT application, 1 US provisional patent, 1 European patent application (EPO).and 3 Greek patents. Books: 1 Textbook on Biopharmaceutics and Pharmacokinetics (in Greek) and 2 Practical course textbooks (in Greek). Corresponding author/pi: in >75% of published work. >800 citations (>600 in last 5 years) h-index 17 (14) Conference Participation/Attendance/Organisation: Participation in more than 90 International conferences or educational workshops, and more than 25 National conferences, Invited speaker in 30 National and International scientific or educational meetings/workshops/conferences. Organization of 4 Workshops (funded by Erasmus/Socrates and Marie Curie) 10-day Workshop Liposome Technology and Applications in Therapeutics and Nanomedicines for drug delivery ( , ; 2003; 2008); Member of organizing committee (or regional committee) of 6 international conferences. Teaching Activities: Undergraduate Courses: Biopharmaceutics and Pharmacokinetics (+Practical course); Pharmaceutical Technology: Pre Formulation / Design and Preparation of Drug Formulation.(+Practical course) Postgraduate Courses: Liposome Technology; Applied Pharmacokinetics, Determination of Drugs in Biological Fluids, Pharmaceutical Statistics, Advanced-Novel Pharmaceutical Formulations (Liquid, Semi-Solid, Solid) Prizes-Honors: : Scholarships from Greek State Scholarships Foundation (IKY) for outstanding performance during undergraduate studies (Ranking in top 5% of class) : Research Fellowship, University of South. California (NIH), L.A, USA : Research Fellowship, University of London (from MOD funded project), London, UK. 2011: First place young investigator award to my student for our poster at EuroNanoForum 2011, May 30 June 1, Budapest, Hungary. Professional Affiliations: - Panhellenic Association of Pharmacists - APGI/APV (Association de Pharmacie Galenique Industrielle) - European Federation of Pharmaceutical Scientists (EUFEPS) -AAPS (Americal Association of Pharm. Scientists) - Controlled Release Society (CRS) - CRS -Greek Chapter [President ] - International Liposome Society (ILS) - Galenos Network for novel Drug delivery Exploitation and Education Professional Activities: Associate Editor Europe for the Jourmal of Biomedical Nanotechnology (2006-). Member of Editorial Board of Journal of Drug Delivery (2010 -). Referee for 35 Pharmaceutical and related Scientific journals. Participation in 3 EU Research Proposal Evaluator panels, EC Research Directorate, 2003, 2004 (FP6) and 2007 (FP7). Evaluator for the Spanish Ministry of Development and Research (after invitation) 2006; Evaluator for a number of foundations (TWAS, Israel Research Council, British cancer Res. Found., Dutch res found., etc.) President of the Western-Greece Committee for evaluation of Pharmacy Technicians (2001-). Evaluator for National Foundation of Drugs (EOF): Bioequivalence Study reviewer (2000-). Scientific Committee Member of European Association of Pharma Biotechnology [EAPB] (2004). Member of Scientific Advisory Board Europe, of official publication of EAPB (2004). Member of the Senate, Univ. of Patras (2004-5). Member of the Graduate Studies committee, Dept. of Pharmacy, Univ. of Patras (1998-). Coordinator of the Erasmus mobility Program for the Dept. of Pharmacy, Univ. of Patras (1998-). 2

3 II] List of most significant publications (maximum 2 pages) P. Macheras, M.Koupparis, S.G.Antimisiaris, Drug Binding and Solubility in Milk, Pharm. Research, 8, 537, 1990 S. G. Antimisiaris, Jayesekera,P., Gregoriadis,G., "Liposomes as vaccine carriers: Incorporation of soluble and particulate antigens in giant vesicles", J. Immunol. Methods, 166, 271,1993 M. Kokona, P. Kallinteri, D. Fatouros, S.G. Antimisiaris*, Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: Effect of lipid composition. Eur. J. Pharm. Sciences (EJPS), 9, 245, 2000 E. Papadimitriou and S.G. Antimisiaris*, Interactions of PC/Chol and PS/Chol liposomes with human cells in vitro, J. Drug Targeting, 8:5, 335, 2000 D. Fatouros, S.G. Antimisiaris*, Physicochemical properties of liposomes incorporating hydrochlorothiazide and chlorothiazide, J. Drug Targeting, 9:1, 61-74, 2001 P. Kallinteri, W-Y. Liao, S.G. Antimisiaris* and K.H.L. Hwang, Characterization, Stability and in-vivo distribution of Fetuin F2 glycopeptide incorporating DSPC/Chol liposomes prepared by mild cholate incubation, J.Drug Targeting, 9:2, 155, D. Fatouros, O. Gortzi, P. Klepetsanis, S.G. Antimisiaris*, etal. Preparation and properties of arsonolipid containing liposomes, Chem. Phys. Lipids, 109, 75-89, Fatouros, K. Haztidimitriou, S.G. Antimisiaris*, Liposomes encapsulating prednisolone and prednisolonecyclodextrin complexes: comparison of membrane integrity and drug release, EJPS, 13, 287, 2001 P.Kallinteri, S. G. Antimisiaris*, Solubility of drugs in the presence of gelatin: effect of drug lipophilicity and degree of ionization, Int. J. Pharm., 221, , O.Gortzi, P. Klepetsanis, S.G. Antimisiaris*, P. V. Ioannou, Capability of arsonolipids to transport divalent cations: A pressman cell study, Chem. Phys. Lipids, 112, 21, P.Kallinteri, E. Papadimitriou, S.G. Antimisiaris*, Targeting of small unilamellar liposomes bearing asialofetuin glycopeptide conjugates to HepG2 cells, J. Liposome. Res., 11(2&3), 175, 2001 O. Gortzi, E. Papadimitriou, S G. Antimisiaris* P. Ioannou, Arsonoliposomes, a novel class of arsenic containing liposomes: Effect of palmitoyl-arsonolipid containing liposomes on the viability of various cancer and normal cells in culture, Pharm. Research, 19:1, 79, P. Kallinteri, S.G.Antimisiaris*, etal. Dexamethasone incorporating liposomes: An in vitro study of their applicability as a slow release delivery system of dexamethasone from covered metallic stents, Biomaterials, 23, 4819, O Gortzi, E. Papadimitriou, S.G. Antimisiaris* P. Ioannou, Cytotoxicity of arsonolipid containing liposomes towards cancer and normal cells in culture: Effect of arsonolipid acyl chain length, EJPS, 18, 2, 175,2003 P. Kallinteri, D. Fatouros, P. Klepetsanis, S.G. Antimisiaris*, Arsenic trioxide liposomes.encapsulation efficiency and in vitro stability, J. Liposome Res., 14 (1-2): 27, 2004 Antimisiaris SG*, Klepetsanis P, Zachariou V, et al. In vivo distribution of arsenic after i.p. injection of arsonoliposomes in balb-c mice. Int J Pharm 289 (1-2): 151, Fatouros DG, Piperoudi S, Gortzi O, Ioannou PV, Antimisiaris SG.*. Physical stability of sonicated arsonoliposomes: Effect of calcium ions. J Pharm Sci-US 94, 46, 2005 Fatouros DG, Klepetsanis P, Ioannou PV, Antimisiaris SG. The effect of ph on the electrophoretic behaviour of a new class of liposomes: arsonoliposomes. Int J Pharm 288 (1): 151, 2005 S.Piperoudi, P.V.Ioannou, P.Frederik, S.G.Antimisiaris*, Arsonoliposomes: Effect of lipid composition on their stability. J Liposome Res 15 (3-4): S. Piperoudi, D. Fatouros,.., S.G. Antimisiaris,*, Incorporation of PEG-lipids in arsonoliposomes can produce highly stable arsenic-containing vesicles of specific lipid composition. Chem. Phys. Lipids 139:2, , G. Koromila, G. Michanetzis, Y.F. Missirlis, S.G.Antimisiaris*, Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents, Biomaterials, 27:12, 2525, 2006 S. Koutsopoulos, DG. Fatouros, PV. Ioannou, SG Antimιsiaris. Thermal behaviour of non-sonicated arsonolipid Dispersions. Biophysical Chemistry, 121:2, 150, 2006 M. Haikou, P. Zagana, PV, Ioannou, SG. Antimisiaris*. Arsonoliposome Interaction with thiols. Effect of pegylation and arsonolipid content on their integrity during incubation in the presence of glutathione. J. Nanosc & Nanotech, 6:2974, 2006 V. Ntimenou, S. Mourtas, E. Christodoulakis, M. Tsilimbaris, S.G. Antimsiaris*. Stability of protein encapsulating DRV liposomes after freeze drying: study with BSA& t-pa. J Liposome Res, 16, 4, , 2006 P. Hatzi, S. Mourtas, P. Klepetsanis, S.G Antimisiaris*. Integrity of liposomes in presence of cyclodextrins. Effect of liposome type and lipid composition, Int. J. Pharm,333 (1-2), pp. 167, S. Mourtas, S. Fotopoulou,.., S.G. Antimisiaris*. Liposomal drugs dispersed in Hydrogels. Effect of liposome, drug and gel properties on drug release kinetics. Colloids and Surf B: Biointerfaces (CS B), 55 (2), pp. 212,

4 M. Zaru, S. Mourtas, P. Klepetsanis, A.M. Fadda and S.G.Antimisiaris*, Liposomes for drug delivery to the lungs after nebulization. Eur. J. Pharmaceut & Biopharm (EJBP), 67 (3), 655, 2007 P. Zagana, P. Klepetsanis, PV. Ioannou, P M. Loiseau, S.G. Antimisiaris* Trypanocidal activity of arsonoliposomes: Effect of vesicle lipid composition, Biomed & Pharmacoth, 61, 499,2007 P. Zagana, M. Haikou, P. Klepetsanis, E. Giannopoulou, P.V. Ioannou, S.G. Antimisiaris*, In vivo distribution of arsonoliposomes: Effect of vesicle lipid composition, Int. J. Pharm, 347 (1-2), 86, 2008 S. Mourtas, S. Duraj, S. Fotopoulou, S.G. Antimisiaris*. Integrity of liposomes in presence of various formulation additives, in aqueous dispersions and in hydrogels, CS B: Biointerfaces, 61 (2), 270, 2008 M-L Manca, S Mourtas, V Drakopoulos, A M Fadda, S G.Antimisiaris*, PLGA, Chitosan or Chitosan-coated PLGA Microparticles for Alveolar Delivery? CS B: Biointerfaces, 62 (2), 220, 2008 S Mourtas, M Haikou, M Theodoropoulou, C Tsakiroglou, S G. Antimisiaris*, How liposome type, composition and loading concentration influence the rheological properties of a liposomal gel. J. Colloid & Inter. Scienc, 317 (2), , 2008 C. Peptu, M. Popa, S.G. Antimisiaris*, Release of Liposome-Encapsulated Calcein from Liposome Entrapping Gelatin- Carboxymethylcellulose Films. J. Nanoscience & Nanotechnology, 8, 2249, M L Manca, G Loy, M Zaru, AM Fadda, SG. Antimisiaris* Release of Rifampicin from Chitosan, PLGA and Chitosan-coated PLGA microparticles, CS B: Biointerfaces, 67, 166, 2008 M Zaru, M-L Manca, A M Fadda S.G. Antimisiaris* Chitosan-coated liposomes for delivery to lungs by nebulization. CS B: Biointerfaces 71 (1), 88, 2009 S. Mourtas, C. Aggelopoulos, P. Klepetsanis, C. Tsakiroglou, S.G. Antimisiaris*, Complex gel formulations for topical drug administration: Rheological properties and aging, Langmuir, 25 (15), pp. 8480, 2009 Favretto, M.E., Marouf, S., Ioannou, P., Antimisiaris, S.G., Parker, T.L. Kallinteri, P. Arsonoliposomes for the potential treatment of medulloblastoma, Pharm. Research 26 (10), 2237, 2009 G. Besson,.., S. Mourtas,.., S. Antimisiaris, M. Kazanji Protective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus Macaques with RT SHIV, Virology 405 (1), 225, 2010 E Markoutsa, G Pampalakis,.., S. G. Antimisiaris*, Uptake and permeability studies of BBB-targeting immunoliposomes using the hcmec/d3 cell line, EJPB, 77: 2, 265, 2011 S. Mourtas, M. Canovi,.., M. Gobbi, S. G. Antimisiaris*, Curcumin-decorated nanoliposomes with very high affinity for amyloid-b1-42 peptide, Biomaterials, 32: 6, 1635, 2011 S. Mourtas, M. KastelloriziosP. Klepetsanis, ( ), S. Antimisiaris*. Immobilization of liposomes on Plasma-treated stainless steel surfaces, by covalent binding. CS B: Biointerfaces, 84 (1), 214, 2011 Canovi, M., Markoutsa, E., Lazar, A.N.,.., Antimisiaris, S.G*.The binding affinity of anti-aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue. Biomaterials 32, 5489, 2011 Stolte-Leeb N, Loddo R, Antimisiaris S, Schultheiss T, Sauermann U, Franz M, Mourtas S, Parsy C, Storer R, Colla PL, Stahl-Hennig C Topical Nonnucleoside Reverse Transcriptase Inhibitor MC 1220 Partially Prevents Vaginal RT-SHIV Infection of Macaques. AIDS Res Hum Retroviruses Mar 23. [Epub] M-T Popescu, S Mourtas, G Pampalakis, S G. Antimisiaris, C Tsitsilianis. ph-responsive Hydrogel/Liposome Soft Nanocomposites For Tuning Drug Release, Biomacromolecules, Articles ASAP July 5, 2011; S. Mourtas, P. Klepetsanis, ( ),S.G. Antimisiaris*. Liposomal gels for vaginal delivery of the microbicide MC1220: Preparation and in vivo vaginal toxicity and pharmacokinetics,.nanolife, accepted, 2011 A.Skouras, S. Mourtas, E. Markoutsa, M-C. De Goltstein, C Wallon, S Catoen, SG. Antimisiaris*. USPIO encapsulating nanoliposomes with high entrapping efficiency, stability and magnetic properties. Nanomedicines (Nanotechnology, Medicine and Biology), in press, M. Taylor, S Moore, S Mourtas, A Niarakis,.., S G Antimisiaris, M Gregori, David Allsop. Effect of curcuminassociated and lipid ligand functionalised nanoliposomes on aggregation ofthe Alzheimer's Aβ peptide. Nanomedicines(Nanotechnology, Medicine and Biology), in press, Book Chapters : G. Gregoriadis, I. Gursel and S.G. Antimisiaris, "Microbe entrapment in giant Liposomes", In : Nonmedical Applications of Liposomes (eds. L. Lasic and Y. Barenholz) CRC-Press, Boca Raton, pg , 1996 S. G. Antimisiaris*, D. Fatouros and P. Kallinteri. Invited Chapter on Liposome Technology, for the Pharmaceutical Manufacturing Handbook, Section 5: New Dosage Forms, Chapter 5.3, Eds. John Wiley and Sons, pp , 2008 S. G. Antimisiaris*. Liposomes in Drug Delivery. Invited chapter for Encyclopedia of Nanoscience and Nanotechnology,

5 III] Significant research achievements in last 10 years (publications, invited talks, patents, awards) A. Publications in high ranking journals: 4 publications in Biomaterials [IF 7.882] (2002, 2006, 2011, 2011) (ranking first in its category) Other journals with IF>3 : Biomacromolecules [IF 5.325] (2011), Nanomedicine (Nanotechnology, Medicine and Biology) [IF 4.882] (2011, 2011), Mol Nutr & Food Res [IF 4.713] (2009) Pharmaceutical Research [IF 4.456] (2002, 2009); EJPB [IF 4.304](2007, 2011), Langmuir (2009) [IF 4.268], International Journal of Pharmaceutics [IF 3.607] (2001, 2005, 2005, 2007, 2008), Virology [IF 3.305] (2010), EJPS [IF 3.291](2001, 2003), J. Coll & Inter Sciences [IF 3.066] (2008), J Pharm Sciences (US) [IF 3.031] (2005), B. Invited publications: Fatouros, PV Ioannou, SG Antimisiaris*. Novel Nanosized Arsenic Containing Vesicles for Drug Delivery: Arsonoliposomes. (Invited Review article) J. Nanoscience & Nanotechnology, 6: , 2006 S.G.Antimisiaris*, G. Koromila, G. Michanetzis, Y.F. Missirlis, Liposome coated stents: A method to deliver drugs to the site of action and improve stent blood-compatibility. (Invited paper) Journal of Liposome Research, Volume 16, 3, , 2006 S.G.Antimisiaris, Arsonoliposomes for Drug Delivery, (Invited Review article) J. Drug Del Scienc & Techn 17, , 2007 Guest Editor for. A Special Issue on Nanomedicines, J. Biomed. Nanotechnol. 4, 217, 2008 P. Zagana, M. Haikou, E. Giannopoulou, P.V. Ioannou, S.G. Antimisiaris*, Arsonoliposome Interaction with cells in culture. Effect of pegylation and lipid composition. (Invited paper for special issue on arsenic), Mol. Nutr. Food Res. 53, , 2009 Antimisiaris, S.G. Arsonoliposomes for drug delivery applications, (invited review) Clinical Lipidology 4 (5), pp , 2009 S. Mourtas, C. Aggelopoulos, P. Klepetsanis, C. Tsakiroglou, S.G. Antimisiaris*, Complex gel formulations for topical drug administration: Rheological properties and aging, (invited paper for special issue on Gels) Langmuir, 25 (15), pp. 8480, 2009 S.G.Antimisiaris, Preparation of DRV liposomes, (invited contribution) Methods in molecular biology (Clifton, N.J.) (2010), 605, ISBN: S.G.Antimisiaris*, P.V. Ioannou, Arsonoliposomes: preparation and physicochemical characterization, (invited contribution) Methods in molecular biology (Clifton, N.J.) (2010), 605, ISBN: S. Mourtas, P. Klepetsanis, ( ),S.G. Antimisiaris*. Liposomal gels for vaginal delivery of the microbicide MC1220: Preparation and in vivo vaginal toxicity and pharmacokinetics, (invited paper for special issue) NanoLife, accepted, 2011 C. Invited Talks: 30 invited talks (from 2001-) in International Conferences, Seminars, Intensive Programs/Workshops or Summer Schools (some listed below): Liposome applications in Transdermal delivery. Socrates IP on Dermal delivery of drugs. University Claude-Bernard I, Dept of Pharmacy, Lyon Sept Liposomes and Cyclodextrins. Socrates IP on Cyclodextrins. University of Lisbon, Dept of Pharmacy, Sept Liposome coated stents: A method to deliver drugs to the site of action and improve stent bloodcompatibility. ILS Conference on Liposome Advances: Progress in Drug and Vaccine Delivery, December, London, 2005 Liposome technology Revisited. In 6th International conference and Workshop on Cell culture and in vitro Models for drug Absorption and Delivery, Theme day: Impact of Nanobiotechnology on New medicines. Saarbruecken, Germany, March 1-10, Liposomes and transdermal delivery of drugs: Incorporation in hydrogels. In Socrates IP on Dermal delivery of drugs. University Claude-Bernard I, Department of Pharmacy, Lyon, September 2006 Controlled release drug delivery systems for intravitreal administration: What can Liposomes do? In Aegean Retina X, July 6-8, Rhodes, GR,

6 Liposomes as a system to prepare Controlled Drug Eluting Biomaterials, in 2nd Interreg School on Advanced Biomaterials, Bari, Italy, May, 2008 Drug Delivery and Targeting Systems- Focus on Liposomes. In Nano2Life Summer School Methods in Micro-Nanotechnology and Nanobiotechnology, (Lecture July 8, 2008), Demokritos, Athens, Greece, Controlled release DDS for Ocular Delivery: Focus on Liposomes, in Seminars on Optics and Vision, Herakleio, Crete, July 8-9, 2008 Arsonoliposomes in Drug Delivery, in 6th Euro Fed Lipids Congress (Oils, Fats & Lipids in the third Millenium). Session: Lipids in Pharmaceutics, Sept. 7-10, Athens, 2008 Liposomes in nanomedicines, in DIMET COURSE Nanoparticles in Medicine Università degli Studi di Milano Bicocca,, MILANO, March 11-13, Nanosized liposomes for on -site controlled-release of active agents, in 5th International Biotechnology Forum (IBSF5), Athens, May 8-9, Nanosized liposomes for construction of drug eluting stents: Improving blood compatibility. In International Conference: From Drug Delivery Systems to Drug Release, Dissolution, IVIVC, BCS, BDDS, Bioequivalence and Biowaivers, May 28-30, Athens Greece, Covalently immobilized liposomes for development of controlled release drug-eluting surfaces: Potential for blood compatibility. in Liposome Advances : Progress in Drug and Vaccine Delivery, Dec , London, UK,2010 Nano-Immunoliposomes for Blood-Brain Barrier (BBB) targeting, in EUROBIC Conference, Thessaloniki, June 2010 Immunoliposomes for Drug Targeting Applications: Results with OX- 26 antibody for Brain Targeting; Intern. Conference on: New Drug Delivery systems, Biosimilars, Bioequivalence, Athens, July 2-3, 2010 Nanoparticulate Drug Delivery systems: Description and Applications, University of Oslo (invited Lecture), September 8, 2010, Oslo Nanoliposomes for targeting AD with therapeuticand diagnostic potential, (Round Table on Nanotechnologies) Panhellenic Pharmaceutical Conference, May 2011, Athens Development of novel nanoparticles with high affinity for Aβ1-42 peptides; 7th Panhellenic International Medical Comference on Alzheimers disease and Related Pathologies, Thessaloniki, February 16-20, 2011 Invited Speaker in Liposome Conference (ILS Society), London Dec 10-13, 2011 D. Patents Liposomes containing particulate materials. WO (A1) Publication date: US Inventor(s): G. Gregoriadis, S.G. Antimisiaris, I. Gursel. A method for immobilization of bioactive substances on surfaces for improving haemocompatibility. Greek Patent, 2006, Inventor(s): S. G. Antimisiaris, I. Missirlis, G. Michanetzis, G. Koromila. Complex formulations for administration of microbicides or other categories of drugs via mucosal (or vaginal or rectal) routes, with high drug-loading capacity and controllable drug release rates. Greek Patent, , 2009, Inventor(s): S.G.Antimisiaris, P.Klepetsanis, S. Mourtas Treatment of Prostate tumors with arsonoliposomes, US Provisional Patent US 61/324,547, April , Inventors: S.G. Antimisiaris, P.V. Ioannou, M. Wei Novel curcumin derivatives with improved physicochemical properties and surface-decorated Nanoliposomes (with the derivatives) with very high affinity for Amyloid-β1-42 peptide. Greek Patent , 2010, [EPO filed] Inventor(s): S.G.Antimisiaris, F. Nicotra, S. Mourtas, C. Zona, B. LaFerla, A. Niaraki. E. Awards: 2011: First place young investigator award to my student A. Skouras for our poster at EuroNanoForum 2011, May 30 June 1, Budapest, Hungary. 6

7 IV] List other Research Projects in which PI has participated in the last 10 years. Funded Research Project SGA has participated in during the last 10-year period ( ): Selection and Development of a microbicide formulation for the prevention of sexual distribution of HIV Large Scale Integrated Project in HEALTH call (FP6) SHIVA ELKE: B227 EC (FP6, Health) PI for UPAT, (Vice-coordinator, WP-leader) Start/End: 450 K euro (Total M euro) 2004/2009 (SHIVA received a 1 year cost-neutral prolongation) Selection and Development of a microbicide formulation for the prevention of sexual distribution of HIV (Matching Funds) SHIVA ELKE: B456 Matching Funds (FP6) Coordinator 89 K euro Start/End: Towards a Euro PhD in Advanced Drug Delivery systems Marie Curie Project in : Early Stage PhD scholarships (FP6) Euro-PhD ELKE: B296 EC (FP6, Marie Curie) PI for UPAT, (WP-leader and Host Lab) 120 K euro (Total 8.10 M euro) Start/End: Towards a Euro PhD in Advanced Drug Delivery systems (Matching Funds) Euro-PhD ELKE: B467 Matching Funds (FP6) Coordinator 19 K euro Start/End: 2004 / 2008 Establishment of A Multidisciplinary Scientific Network For The Development And Application Of Biomaterials - ELKE: B277 EC (INTERREG IIIa Greece-Italy) Partner of UPAT group/ PI for Pharm-TECH, (WP-leader) 110 K euro (Total 1.10 M euro) Start/End: 2006 /

8 6 7 8 Nanomedicines: Nanoparticulate for Drug Delivery (for organization of Intensive Program - Workshop) IP-Nano ELKE: C512 EC (LLL-Erasmus) Coordinator 41 K euro Start/End: Nanoparticles for Therapy and Diagnosis of Alzheimer Disease Large scale project in NMP(Nanotechnology-Materials-Processes) NAD ELKE: C510 EC (FP7, NMP) PI for UPAT, (WP-leader) 785 K euro (Total 14.7 M euro) Start/End: 2008 / 2013 Nanoparticles for Therapy and Diagnosis of Alzheimer Disease MATCHING FUNDS NAD ELKE: C977 Matching Funds (FP7) coordinator K euro Start/End: 2008/ 8

Ikerbasque Research Professor, Centre for Cooperative Research in Biomaterials, CIC. biomagune, 20009, San Sebastián, Spain

Ikerbasque Research Professor, Centre for Cooperative Research in Biomaterials, CIC. biomagune, 20009, San Sebastián, Spain Luis M. Liz- Marzán Ikerbasque Research Professor, Centre for Cooperative Research in Biomaterials, CIC. biomagune, 20009, San Sebastián, Spain Current Position: L UIS M. LIZ- MARZÁN Education: Bachelor

More information

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more: www.aaps.org/forstudents

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more: www.aaps.org/forstudents Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aaps.org/forstudents How Do I Know If a Career in the Pharmaceutical Sciences is Right

More information

Safe Nano Design Molecule Manufacturing Market

Safe Nano Design Molecule Manufacturing Market August 14 16, 212 College of Nanoscale Science & Engineering (CNSE) of the University at Albany National Institute for Occupational Safety and Health (NIOSH) Prevention through Design Program Safe Nano

More information

A FDA Perspective on Nanomedicine Current Initiatives in the US

A FDA Perspective on Nanomedicine Current Initiatives in the US A FDA Perspective on Nanomedicine Current Initiatives in the US Carlos Peña, PhD Office of the Commissioner FDA September 3, 2010 Outline Context Nanotechnology Task Force report summary Identification

More information

DURGARAMANI SIVADASAN

DURGARAMANI SIVADASAN DURGARAMANI SIVADASAN Department of Pharmaceutics College of Pharmacy Jizan University, KSA Mobile: 0534769912 E mail : durgimural@rediffmail.com --------------------------------------------------------------------------------------------------------------------------

More information

Assoc. Prof. Dr. M. Aylin DELİORMANLI

Assoc. Prof. Dr. M. Aylin DELİORMANLI Assoc. Prof. Dr. M. Aylin DELİORMANLI EDUCATION Degree University Department / Program Undergrad Ege University Chemical Engineering 99 99 M.S. Izmir Institute of Tech. Materials Science and Engineering

More information

Fachgruppe Drug Delivery

Fachgruppe Drug Delivery industrial career at Beiersdorf-Lilly GmbH, Hamburg Bernd Riebesehl, Ph. D. completed his thesis on solubilization at the TU Braunschweig in 1992. He started his leading a lab for preformulation and line

More information

University-wide Courses/Seminars These 4 courses are offered by the Graduate School:

University-wide Courses/Seminars These 4 courses are offered by the Graduate School: PROGRAMMES OF STUDY Institute of Chinese Medical Sciences PhD Programme AREAS OF STUDY Biomedical Sciences University-wide Courses/Seminars These 4 courses are offered by the Graduate School: GRSC801 Research

More information

Introduction to pharmaceutical technology

Introduction to pharmaceutical technology Introduction to pharmaceutical technology Marie Wahlgren Chapter 1 What is the topics of today Introduction to the course Introduction to the project assignment How to choose a new drug formulation 1 Contacts

More information

Pharmaceutical Sciences

Pharmaceutical Sciences Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aapspharmaceutica.com/students How do I know if a career in the pharmaceutical sciences

More information

European Continuing Education College

European Continuing Education College Design and Development of Conventional and Modified Release Oral Drug Delivery Systems Three Day Intensive Course for Managers, Scientists and Technicians with the Emphasis on the Principles of Oral Drug

More information

Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare

Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare Paula Corabian, Dagmara Chojecki March 6, 2012 Objectives Provincial Health Technology Assessment (HTA) Program

More information

The National Centre for Biomedical Engineering Science

The National Centre for Biomedical Engineering Science The How this Integrated Technology Platform has impacted the development of R&D Clusters in Galway Jacinta Thornton, PhD Executive Manager, NCBES National Centre for Biomedical Engineering g Science Mission

More information

PharmaForum 2009, am 3. November in Frankfurt

PharmaForum 2009, am 3. November in Frankfurt Across Barriers GmbH Tel: +49 681 959 18-800 Science Park 1 Fax: +49 681 959 18-802 66123 Saarbrücken e-mail: sales@acrossbarriers.de http://www.acrossbarriers.de PharmaForum 2009, am 3. November in Frankfurt

More information

Curriculum Vitae. Education. Brief Chronology of Employment. Academic Positions held. Pier Paolo Di Fiore M.D. Ph.D.

Curriculum Vitae. Education. Brief Chronology of Employment. Academic Positions held. Pier Paolo Di Fiore M.D. Ph.D. Pier Paolo Di Fiore M.D. Ph.D. Curriculum Vitae Education 1981 - M.D., summa cum laude, University of Naples, 2nd Medical School, Naples, Italy 1984 - Board in Oncology, summa cum laude, University of

More information

APPLICATION OF NANOPARTICLE IN CANCER TREATMENT

APPLICATION OF NANOPARTICLE IN CANCER TREATMENT APPLICATION OF NANOPARTICLE IN CANCER TREATMENT Introduction Nanotechnology is the design, characterization, production and application of structures, devices and systems by controlling shape and size

More information

Kick-off meeting. Barcelona, 3-5 March 2014 08.04.2014 1

Kick-off meeting. Barcelona, 3-5 March 2014 08.04.2014 1 Kick-off meeting Barcelona, 3-5 March 2014 08.04.2014 1 UCL- overview Known as 'London's Global University', University College London employs 4,078 academic research staff in over 50 departments and institutes.

More information

Bundesinstitut für Arzneimittel und Medizinprodukte. Dissolution Testing. Analytik,Methodenentwicklung, Bioäquivalenz SAQ. Olten, 25.

Bundesinstitut für Arzneimittel und Medizinprodukte. Dissolution Testing. Analytik,Methodenentwicklung, Bioäquivalenz SAQ. Olten, 25. Dissolution Testing Analytik,Methodenentwicklung, Bioäquivalenz SAQ Olten, 25. Januar 2006 Dr. H. Potthast (h.potthast@bfarm.de) 1 2 Basis for Biowaiver Applications/Decisions Note for Guidance on the

More information

ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals. Step 5

ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals. Step 5 European Medicines Agency July 1996 CPMP/ICH/140/95 ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON THE NEED FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS

More information

Accreditation of Master of Pharmacy Degrees

Accreditation of Master of Pharmacy Degrees Accreditation of Master of Pharmacy Degrees Interim standards, Sept 2010 Introduction This document sets out the standards against which we, the General Pharmaceutical Council (GPhC), will accredit those

More information

Absorption of Drugs. Transport of a drug from the GI tract

Absorption of Drugs. Transport of a drug from the GI tract Absorption of Drugs Absorption is the transfer of a drug from its site of administration to the bloodstream. The rate and efficiency of absorption depend on the route of administration. For IV delivery,

More information

Overview of Dissolution for BA/BE

Overview of Dissolution for BA/BE Biopharmaceutics Classification System based on Solubility/Permeability Biowaivers for BCS I Drugs Discussion of BCS III Drugs Models establishing in vivo-in vitro Correlations (IVIVC Levels A-C) 1 Biopharmaceutics

More information

CHEMICAL SCIENCES REQUIREMENTS [61-71 UNITS]

CHEMICAL SCIENCES REQUIREMENTS [61-71 UNITS] Chemical Sciences Major Chemistry is often known as the central science because of the key position it occupies in modern science and engineering. Most phenomena in the biological and Earth sciences can

More information

AAGPs TM Anti-Aging Glyco Peptides. Enhancing Cell, Tissue and Organ Integrity Molecular and biological attributes of lead AAGP molecule

AAGPs TM Anti-Aging Glyco Peptides. Enhancing Cell, Tissue and Organ Integrity Molecular and biological attributes of lead AAGP molecule AAGPs TM Anti-Aging Glyco Peptides Enhancing Cell, Tissue and Organ Integrity Molecular and biological attributes of lead AAGP molecule 1 Acknowledgements This presentation was prepared by Dr. Samer Hussein

More information

Symposium on Innovation in Healthcare Technology and Delivery

Symposium on Innovation in Healthcare Technology and Delivery Symposium on Innovation in Healthcare Technology and Delivery March 10, 2014, 1-6pm, Stevens Babbio Center, Hoboken NJ 1:00-1:30 Opening Remarks Nariman Farvardin, PhD, Professor and University President,

More information

GDUFA Regulatory Science Update

GDUFA Regulatory Science Update GDUFA Regulatory Science Update Robert Lionberger, Ph.D. Director Office of Research and Standards Office of Generic Drugs Center for Drug Evaluation and Research, FDA GPhA Annual Meeting Feb 9, 2015 Goals

More information

Overview of the Research Programs of School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University

Overview of the Research Programs of School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University Overview of the Research Programs of School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University Mission To bridge and integrate engineering technology and medical sciences

More information

Salute in Horizon 2020: Giornata Nazionale di Lancio dei bandi 2014-15

Salute in Horizon 2020: Giornata Nazionale di Lancio dei bandi 2014-15 Salute in Horizon 2020: Giornata Nazionale di Lancio dei bandi 2014-15 Collaborazione tra Università e Industria in un progetto europeo "Innovation 2" del Settimo Programma Quadro (FP7): THINPAD - Maurizio

More information

CAREERS IN BIOMEDICAL SCIENCE & THE IBMS. Betty Kyle Scottish Regional Representative IBMS Lead Biomedical Scientist NHS Lanarkshire

CAREERS IN BIOMEDICAL SCIENCE & THE IBMS. Betty Kyle Scottish Regional Representative IBMS Lead Biomedical Scientist NHS Lanarkshire CAREERS IN BIOMEDICAL SCIENCE & THE IBMS Betty Kyle Scottish Regional Representative IBMS Lead Biomedical Scientist NHS Lanarkshire What is a biomedical scientist? Biomedical scientists carry out investigations

More information

Pharmaceutical Nanotechnology

Pharmaceutical Nanotechnology Pharmaceutical Nanotechnology Pharmaceutical Nanotechnology Development of Gold-Chitosan-coated PLGA Nanoparticles Marius Hittinger 28.04.2011 Supervisor: Juniorprofessor Dr. Marc Schneider Pharmaceutical

More information

BioTalentum Ltd. Hungary Prof. András Dinnyés Director

BioTalentum Ltd. Hungary Prof. András Dinnyés Director BioTalentum Ltd. Hungary Prof. András Dinnyés Director Foto a cég épületéről Novel Transgenic Animal Models, Cellular Models and Stem Cell Systems for Biomedical Research and Drug Testing Fourth EUA CDE

More information

RESEARCH INTERESTS Biotechnology, Vaccines, Drug Delivery and Drug Targeting, Nanotechnology, Formulation of poorly soluble compounds

RESEARCH INTERESTS Biotechnology, Vaccines, Drug Delivery and Drug Targeting, Nanotechnology, Formulation of poorly soluble compounds Genada SINANI Istanbul Kemerbugaz University School of Pharmacy, Department of Pharmaceutical Technology Kartaltepe Mah. İncirli cad. No:11 Bakırköy/İstanbul, Turkey Tel: +90 212 709 45 28 Email: genada.sinani@kemerburgaz.edu.tr

More information

Curriculum Vitae Harvard Medical School/ Harvard School of Dental Medicine

Curriculum Vitae Harvard Medical School/ Harvard School of Dental Medicine Curriculum Vitae Harvard Medical School/ Harvard School of Dental Medicine Date Prepared: November 16, 2009 Name: Zafira Castaño Corsino, Ph.D. Work Phone: (34) 659306730 Work Email: Place of Birth: zcastan@hotmail.com

More information

A Letter from MabVax Therapeutics President and Chief Executive Officer

A Letter from MabVax Therapeutics President and Chief Executive Officer A Letter from MabVax Therapeutics President and Chief Executive Officer Dear Fellow Stockholder: You have invested in MabVax Therapeutics because you share our passion for finding new therapies for the

More information

Peptide and Sustained Release Technology to Treat Ocular Diseases and Cancer

Peptide and Sustained Release Technology to Treat Ocular Diseases and Cancer Peptide and Sustained Release Technology to Treat Ocular Diseases and Cancer Jordan Green, PhD, Co-Founder and CEO Wendy Perrow, MBA, Senior Business Advisor February 11, 2015 www.asclepix.com Advantages

More information

Department of Environmental Science and Technology. MSc in Energy Resource Management

Department of Environmental Science and Technology. MSc in Energy Resource Management Department of Environmental Science and Technology MSc in Energy Resource Management Vision and Mission of the Department Vision The establishment of an internationally recognized Department in the field

More information

CURRICULUM VITAE ACADEMIC APPOINTMENTS

CURRICULUM VITAE ACADEMIC APPOINTMENTS CURRICULUM VITAE PERSONAL DATA Name Citizenship Do not include information such as date of birth, gender, marital status, spouse, children s names or ages, etc. ADDRESS Professional Address Telephone Number

More information

Future Oncology: Technology, Products, Market and Service Opportunities

Future Oncology: Technology, Products, Market and Service Opportunities Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter

More information

In vitro co-culture model of the inflamed intestinal mucosa

In vitro co-culture model of the inflamed intestinal mucosa In vitro co-culture model of the inflamed intestinal mucosa Berlin, December 13, 2011 Eva-Maria Collnot, e.collnot@mx.uni-saarland.de Helmholtz Institute for Pharmaceutical Research Saarland Departement

More information

Eventuale spazio per nome struttura o altro. Pharmacy education. The Italian academic viewpoint

Eventuale spazio per nome struttura o altro. Pharmacy education. The Italian academic viewpoint Eventuale spazio per nome struttura o altro Pharmacy education. The Italian academic viewpoint Faculty of Pharmacy Total number of Pharmacy higher education institutes in Italy 1. Faculty of Pharmacy,

More information

Masters Learning mode (Форма обучения)

Masters Learning mode (Форма обучения) Program Title (Название программы): Pharmacology Degree (Степень) Masters Learning mode (Форма обучения) Full-time and part-time Duration of study (Продолжительность программы) 2 years (4 years part time)

More information

UK- India Science Bridge: BioPharm 2020

UK- India Science Bridge: BioPharm 2020 DST INDIA - RESEARCH COUNCILS UK UK- India Science Bridge: BioPharm 2020 Entrepreneurial Opportunities for Indian and UK Scientists in the Pharmaceutical and Biotechnology Industries UK-India Impact Symposium

More information

Amel Abd Allah Hashim Ahmed

Amel Abd Allah Hashim Ahmed Amel Abd Allah Hashim Ahmed Lecturer of Biochemistry & Molecular Biology PERSONAL PROFILE Nationality: Egyptian Work: Faculty of Pharmacy, Helwan University, Ain-Helwan, Helwan, Egypt. Work phone: 25590000-

More information

Postgraduate Studies in Health Informatics in Greece

Postgraduate Studies in Health Informatics in Greece 261 Postgraduate Studies in Health Informatics in Greece John Mantas Laboratory of Health Informatics, Faculty of Nursing, University of Athens, Greece Abstract Health informatics is a well established

More information

Medical & Health Sciences

Medical & Health Sciences School of Postgraduate Studies Medical & Health Sciences (MSc /PhD by Research) 2016 What Is IMU s Medical & Health Sciences (by Research) Programme About? Overview Postgraduate research forms a major

More information

Production of ferrite nanopowders in radiofrequency thermal plasma

Production of ferrite nanopowders in radiofrequency thermal plasma Production of ferrite nanopowders in radiofrequency thermal plasma PhD Theses Loránd Gál Budapest, 2008 HAS Chemical Research Center Institute of Materials and Environmental Chemistry Department of Plasma

More information

Custom Antibody Services

Custom Antibody Services prosci-inc.com Custom Antibody Services High Performance Antibodies and More Broad Antibody Catalog Extensive Antibody Services CUSTOM ANTIBODY SERVICES Established in 1998, ProSci Incorporated is a leading

More information

Profile of Biomedical Research and Biotechnology Commercialization. San Diego Metropolitan Statistical Area

Profile of Biomedical Research and Biotechnology Commercialization. San Diego Metropolitan Statistical Area Profile of Biomedical Research and Biotechnology Commercialization San Diego Metropolitan Statistical Area Overview and History of Biotechnology in San Diego San Diego has a significant concentration of

More information

Biopharmaceutical Process Evaluated for Viral Clearance

Biopharmaceutical Process Evaluated for Viral Clearance Authored by S. Steve Zhou, Ph.D. Microbac Laboratories, Inc., Microbiotest Division The purpose of Viral Clearance evaluation is to assess the capability of a manufacturing production process to inactivate

More information

Pharmacy Technician Diploma (Part Time) - SC232

Pharmacy Technician Diploma (Part Time) - SC232 Pharmacy Technician Diploma (Part Time) - SC232 1. Special Note The Programme is designed to be a professional course, like the Diploma/BSc (Hons) Biomedical Sciences and the Diploma/BSc (Hons) Occupational

More information

HyStem. Hydrogels CELLULAR MATRICES FOR TRANSLATIONAL RESEARCH. esibio.com

HyStem. Hydrogels CELLULAR MATRICES FOR TRANSLATIONAL RESEARCH. esibio.com HyStem Hydrogels CELLULAR MATRICES FOR TRANSLATIONAL RESEARCH HyStem Hydrogel Extracellular Matrices Chemically-defined For use in 2D and 3D formats in vitro and in vivo applications Customizable for many

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Food-Effect Bioavailability and Fed Bioequivalence Studies U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)

More information

QUALITY, SAFETY AND EFICACY ASSESSOR

QUALITY, SAFETY AND EFICACY ASSESSOR Curriculum vitae PERSONAL INFORMATION Javier Alonso Naveda WORK EXPERIENCE March 2014 Present SUPPORT CVMP MEMBER, CENTRALIZED MANAGEMENT PROCEDURES, REFERRALS, QRD, QUALITY ASSESSOR Support to the CVMP

More information

College of Pharmacy & Pharmaceutical Sciences Graduate Catalog 2015-2016

College of Pharmacy & Pharmaceutical Sciences Graduate Catalog 2015-2016 College of Pharmacy & Pharmaceutical Sciences Graduate Catalog 2015-2016 Degrees Offered Doctor of Philosophy in Experimental Therapeutics Doctor of Philosophy in Medicinal Chemistry Master of Science

More information

Nanomedicine in Horizon 2020

Nanomedicine in Horizon 2020 Nanomedicine in Horizon 2020 Heico FRIMA Programme Officer European Commission Directorate-General for Research & Directorate D: Key Enabling Technologies heico.frima@ec.europa.eu ETPN Annual Event 2014

More information

Biomedical Engineering Graduate Program in METU / ANKARA

Biomedical Engineering Graduate Program in METU / ANKARA Biomedical Engineering Graduate Program in METU / ANKARA Faculty of Engineering Institute of Applied Mathematics Informatics Institute Faculty of Arts and Sciences Electrical and Electronics and Engineering

More information

: Married, father of 31 years old son and 21 years old daughter

: Married, father of 31 years old son and 21 years old daughter CURRICULUM VITAE Name Date of Birth Place of Birth Nationality Marital Status : Abdurrazak Öncü : July 5th1955 : Kırıkkale, : Turkish : Married, father of 31 years old son and 21 years old daughter EDUCATION

More information

Course Curriculum for Master Degree in Clinical Pharmacy

Course Curriculum for Master Degree in Clinical Pharmacy Course Curriculum for Master Degree in Clinical Pharmacy The Master Degree in Clinical Pharmacy is awarded by the Faculty of Graduate studies at Jordan University of Science and Technology (JUST) upon

More information

Theranostics: A combination of diagnostics and therapy

Theranostics: A combination of diagnostics and therapy Theranostics: A combination of diagnostics and therapy Professor Peter Dobson Academic Director Oxford University Begbroke Science Park, Oxford, England Theranostics: the possible scenarios Therapeutic

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GUIDELINE ON THE NEED FOR CARCINOGENICITY STUDIES

More information

DEPARTMENT OF ZOOLOGY M.D. UNIVERSITY, ROHTAK

DEPARTMENT OF ZOOLOGY M.D. UNIVERSITY, ROHTAK DEPARTMENT OF ZOOLOGY M.D. UNIVERSITY, ROHTAK 1. Faculty profile 1. Name of the Faculty Member : Dr. Minakshi Sharma 2. Designation : Associate Professor 3. Contact : Ph.01262 393065; 09996211189 email:sminakshi.2007@rediffmail.com

More information

Perspectives on the Future of Graduate Education in Medicinal Chemistry and Pharmacognosy 1

Perspectives on the Future of Graduate Education in Medicinal Chemistry and Pharmacognosy 1 Perspectives on the Future of Graduate Education in Medicinal Chemistry and Pharmacognosy 1 Robert W. Brueggemeier College of Pharmacy, The Ohio State University, Columbus, OH 43210-1291 INTRODUCTION Graduate

More information

1150 W. Medical Center Dr. Research Investigator Ann Arbor, MI 48109 Department of Microbiology and Immunology phone: (734)763-5364

1150 W. Medical Center Dr. Research Investigator Ann Arbor, MI 48109 Department of Microbiology and Immunology phone: (734)763-5364 Alteri, Christopher J. 5641 Medical Science Bldg. II 1150 W. Medical Center Dr. Research Investigator Ann Arbor, MI 48109 Department of Microbiology and Immunology phone: (734)763-5364 University of Michigan

More information

CLINICAL DEPARTMENTS STATEMENT OF FACULTY ORGANIZATION, STANDARDS AND CRITERIA FOR RANK (Approved 9/27/94) (Revised 10/13/04, 12/20/05, 12/2007)

CLINICAL DEPARTMENTS STATEMENT OF FACULTY ORGANIZATION, STANDARDS AND CRITERIA FOR RANK (Approved 9/27/94) (Revised 10/13/04, 12/20/05, 12/2007) CLINICAL DEPARTMENTS STATEMENT OF FACULTY ORGANIZATION, STANDARDS AND CRITERIA FOR RANK (Approved 9/27/94) (Revised 10/13/04, 12/20/05, 12/2007) INTRODUCTION Each Clinical Department 1 will develop the

More information

Nanotechnology in Cancer Treatment and Detection. Richard Acosta

Nanotechnology in Cancer Treatment and Detection. Richard Acosta Nanotechnology in Cancer Treatment and Detection Richard Acosta Motivation Ineffectiveness of many Cancer treatments Numerous side effects Difficulties in early Cancer detection No immunization Scale and

More information

Key Results of 2008 Leem Nanomedecine Study

Key Results of 2008 Leem Nanomedecine Study Key Results of 2008 Leem Nanomedecine Study Nanobio Dialogue Session Annick Schwebig,, M.D., General Manager, Actelion Pharmaceuticals France Vice-President of Leem Biotech Committee EuroBio,, Paris, October

More information

Undergraduate Biomedical Engineering Curriculum University of North Carolina at Chapel Hill, 2014-2015

Undergraduate Biomedical Engineering Curriculum University of North Carolina at Chapel Hill, 2014-2015 Undergraduate Biomedical Engineering Curriculum University of North Carolina at Chapel Hill, 2014-2015 First two years Fall: BMME 101 Frontiers of Biomedical Engineering (strongly recommended but not required;

More information

KMS-Specialist & Customized Biosimilar Service

KMS-Specialist & Customized Biosimilar Service KMS-Specialist & Customized Biosimilar Service 1. Polyclonal Antibody Development Service KMS offering a variety of Polyclonal Antibody Services to fit your research and production needs. we develop polyclonal

More information

UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA

UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA Dr. Henry Daniell Pegasus Professor & University Board of Trustee Chair Dept. Mol.

More information

The Postgraduate Course Toxicology Vienna

The Postgraduate Course Toxicology Vienna The Postgraduate Course Toxicology Vienna Completion as Master of Science (Toxicology) Beginning of next course: Summer term 2016 OPEN FOR REGISTRATION AT ANY TIME Contents: History Objectives Participants

More information

Laboratory medicine as one of the pharmacists competencies

Laboratory medicine as one of the pharmacists competencies 2014 EAFP Annual Conference Laboratory medicine as one of the pharmacists competencies Borut Božič Examinations of the body fluids in order to recognize the state of health of the individuals Greco-Roman

More information

THE LINCOLN INSTITUTE OF HEALTH

THE LINCOLN INSTITUTE OF HEALTH THE LINCOLN INSTITUTE OF HEALTH Background The Chair in the Care of the Older Person will be part of the new Lincoln Institute of Health, a cross disciplinary research collaboration linking schools, colleges

More information

SÁNCHEZ MARGALLO, Francisco Miguel

SÁNCHEZ MARGALLO, Francisco Miguel SÁNCHEZ MARGALLO, Francisco Miguel Dr. Sánchez is the Scientific Director at the Jesús Usón Minimally Invasive Surgery Centre (JUMISC) located in Cáceres, Spain. The JUMISC is a multidisciplinary institution

More information

Non-clinical development of biologics

Non-clinical development of biologics Aurigon Life Science GmbH Non-clinical development of biologics Requirements, challenges and case studies Committed to Life. Sigrid Messemer vet. med. M4 Seminar March 10 th 2014 Aurigon - your full service

More information

THOMAS C. RANSOHOFF Vice President and Principal Consultant

THOMAS C. RANSOHOFF Vice President and Principal Consultant THOMAS C. RANSOHOFF Vice President and Principal Consultant +1.781.281.2704 (o) +1.617.759.4109 (m) transohoff@bptc.com Profile An expert in the development and scale up of biopharmaceutical processes;

More information

The University of Cincinnati is an affirmative action/equal opportunity employer.

The University of Cincinnati is an affirmative action/equal opportunity employer. Position #214UC7312 The University of Cincinnati James L. Winkle College of Pharmacy invites applications for a full- time, non- tenure track, 12- month clinical faculty position in the Division of Pharmacy

More information

A Novel Bioconjugation Technology

A Novel Bioconjugation Technology A Novel Bioconjugation Technology for Assay Development and More! Presentation overview Who we are Solutions we provide for our customers Solulink s technology Linking system The Solulink advantage Applications

More information

Bachelor of Science in Pharmaceutical Sciences (BSPS) Program Overview and Internship Requirements

Bachelor of Science in Pharmaceutical Sciences (BSPS) Program Overview and Internship Requirements Bachelor of Science in Pharmaceutical Sciences (BSPS) Program Overview and Internship Requirements Pharmaceutical Sciences Applied sciences that underlie the practice of pharmacy the development, manufacture,

More information

Introduction to Enteris BioPharma

Introduction to Enteris BioPharma Introduction to Enteris BioPharma Enteris BioPharma Intelligent Solutions for Oral Drug Delivery Privately held, New Jersey based biotech company Owned solely by Victory Park Capital, a large Chicago based

More information

Biomedical Engineering Department Cornell University

Biomedical Engineering Department Cornell University Biomedical Engineering Department Cornell University Our department offers three degree programs. The PhD is a research degree which usually requires approximately 5 years depending on the success of the

More information

Kazan (Volga region) Federal University, Kazan, Russia Institute of Fundamental Medicine and Biology. Master s program.

Kazan (Volga region) Federal University, Kazan, Russia Institute of Fundamental Medicine and Biology. Master s program. Kazan (Volga region) Federal University, Kazan, Russia Institute of Fundamental Medicine and Biology Master s program Bioinformatics I. THEORETICAL BASIS The development of effective technologies of theoretical

More information

www.iproteos.com Corporate Presentation November, 2013

www.iproteos.com Corporate Presentation November, 2013 www.iproteos.com Corporate Presentation November, 2013 The company Iproteos is an early-stage drug development company founded in 2011: Spin-Out from Institute for Research in Biomedicine (IRB Barcelona)

More information

Generic drugs are copies of innovator drug products

Generic drugs are copies of innovator drug products dx.doi.org/10.14227/dt190412p51 In Vitro Equivalence Studies of Generic Metformin Hydrochloride Tablets and Propranolol Hydrochloride Tablets Under Biowaiver Conditions in Lagos State, Nigeria e-mail:

More information

INSTITUTE OF CLINICAL PHARMACY

INSTITUTE OF CLINICAL PHARMACY INSTITUTE OF CLINICAL PHARMACY TEL: 886-6-353535 ext. 568 FAX: 886-6-37349 E-MAIL:em75500@email.ncku.edu.tw BRIEF INTRODUCTION Many departments and institutes have been established since 984, when National

More information

WE ARE FUTURE LEADERS

WE ARE FUTURE LEADERS WE ARE FUTURE LEADERS WE ARE THE DEPARTMENT OF BIOENGINEERING Why should you study biomedical engineering? Of all the engineering disciplines, none has the power to transform lives quite so dramatically

More information

European Continuing Education College

European Continuing Education College Principles of Tablet and Capsule Formulation Three Day Intensive Course for Scientists, Managers and Technicians Holiday Inn Hotel, Oxford Circus, London, UK 12th, 13th and 14th October 2015 Course Background

More information

Chemical Engineering - CHEN

Chemical Engineering - CHEN Auburn University 1 Chemical Engineering - CHEN Courses CHEN 2100 PRINCIPLES OF CHEMICAL ENGINEERING (4) LEC. 3. LAB. 3. Pr. (CHEM 1110 or CHEM 1117 or CHEM 1030) and (MATH 1610 or MATH 1613 or MATH 1617

More information

Research Fellow Mucosal Immunity Fixed Term (full-time); 2 years Advanced Materials and BioEngineering Research Department/School:

Research Fellow Mucosal Immunity Fixed Term (full-time); 2 years Advanced Materials and BioEngineering Research Department/School: Post Specification Post Title: Research Fellow Mucosal Immunity Post Status: Fixed Term (full-time); 2 years Advanced Materials and BioEngineering Research Department/School: (AMBER) / School of Biochemistry

More information

Call 2014: High throughput screening of therapeutic molecules and rare diseases

Call 2014: High throughput screening of therapeutic molecules and rare diseases Call 2014: High throughput screening of therapeutic molecules and rare diseases The second call High throughput screening of therapeutic molecules and rare diseases launched by the French Foundation for

More information

BioBusiness Biopharmaceutical Ingredients Recombinant albumins & albumin fusion Dermot Pearson, Strategic Product Director, NZ Biopharma

BioBusiness Biopharmaceutical Ingredients Recombinant albumins & albumin fusion Dermot Pearson, Strategic Product Director, NZ Biopharma BioBusiness Biopharmaceutical Ingredients Recombinant albumins & albumin fusion Dermot Pearson, Strategic Product Director, NZ Biopharma 2 Novozymes solutions dedicated to the biopharmaceutical industry

More information

& the Engineer. Guest Lecture Introduction to Engineering 160 November 17 & 18, 2004 University of Wisconsin, Madison

& the Engineer. Guest Lecture Introduction to Engineering 160 November 17 & 18, 2004 University of Wisconsin, Madison Nanotechnology, Society, & the Engineer Guest Lecture Introduction to Engineering 160 November 17 & 18, 2004 University of Wisconsin, Madison Outline for Today Introduction to Nano [Charlie Tahan] Group

More information

CPCTAS was a project financed under the 7th Framework Programme within Regions of knowledge Work Programme through the Coordination and Support Action

CPCTAS was a project financed under the 7th Framework Programme within Regions of knowledge Work Programme through the Coordination and Support Action CPCTAS Centre for Pre-Clinical Testing of Active Substances LCMB Laboratory for Cell and Molecular Biology Snežana Marković, Ph.D. assistant professor Head of the Lab Faculty of Science University of Kragujevac,

More information

Appendices Master s degree programme Biomedical Engineering 2011-2012

Appendices Master s degree programme Biomedical Engineering 2011-2012 Appendices Master s degree programme Biomedical Engineering 2011-2012 Appendix A Learning outcomes of the degree programme (art. 1.3) The graduate in Biomedical Engineering (BME): 1. has basic knowledge

More information

Biology meets Engineering

Biology meets Engineering UIC Bioengineering What is Bioengineering? Biology meets Engineering The term bioengineering is often used interchangeably with: Biomedical Engineering synonymous (as far as accreditation goes ABET) Biological

More information

CURRICULUM VITAE. Vassilia L. Ninni Associate Professor Department of Business Administration Athens University of Economics and Business

CURRICULUM VITAE. Vassilia L. Ninni Associate Professor Department of Business Administration Athens University of Economics and Business CURRICULUM VITAE Vassilia L. Ninni Associate Professor Department of Business Administration Athens University of Economics and Business Athens 2010 CURRICULUM VITAE 1. Personal Information Name: Vassilia

More information

2011 Annual Report T H E NANOTECHNOLOGY I N S T I T U T E

2011 Annual Report T H E NANOTECHNOLOGY I N S T I T U T E 2011 Annual Report T H E NANOTECHNOLOGY TM I N S T I T U T E The Nanotechnology Institute The Nanotechnology Institute (NTI) is southeastern Pennsylvania s first multi-institutional partnership created

More information

GRADUATE DEGREES IN THE COLLEGE OF PHARMACY. One college. Two campuses.

GRADUATE DEGREES IN THE COLLEGE OF PHARMACY. One college. Two campuses. GRADUATE DEGREES IN THE COLLEGE OF PHARMACY One college. Two campuses. University of Illinois at Chicago College of Pharmacy Phone: (312) 996-7242 Fax: (312) 996-3272 Chicago 833 South Wood Street (MC

More information

UNCOVERING OPPORTUNITIES IN THE BIOTECH SECTOR - BRAZIL

UNCOVERING OPPORTUNITIES IN THE BIOTECH SECTOR - BRAZIL UNCOVERING OPPORTUNITIES IN THE BIOTECH SECTOR - BRAZIL INTRODUCTION BY INNOVATION CENTRE DENMARK IN SAO PAULO BRAZILIAN BIOTECHNOLOGY SECTOR The Ministry of Science, Technology and Innovation (MCTI) considers

More information

The Commercialization of Technology Concepts into Medical Products

The Commercialization of Technology Concepts into Medical Products The Commercialization of Technology Concepts into Medical Products Kevin J. Scanlon, Ph.D. New Zealand 2006 International BioScience Overview Pharmaceutical Industry Biotechnology Startups Investment Community

More information